When was Biotia founded?

Biotia was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is Biotia located?

Biotia is headquartered in Brooklyn, United States. It is registered at 1867 STOCKHOLM ST.,APT. 1,RIDGEWOOD,NY,11385.

Who is the current CEO of Biotia?

Niamh O'Hara of Biotia. They have also founded 1 company.

How many employees does Biotia have?

As of Sep 30, 2026, the latest employee count at Biotia is 27.

Is Biotia a funded company?

Biotia is a funded company, having raised a total of $19.4M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 10, 2019.

When was the latest funding round of Biotia?

Biotia's latest funding was a $***** Series B round on Oct 01, 2026, with participation from 9 investors.

Where does Biotia rank among its competitors?

Biotia ranks 6th amongst 40 active competitors, of which 19 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was mbiomics, which secured $14.1M in Apr, 2026.

Who are the top competitors of Biotia?

Biotia's top competitors include Kallyope, Manus Bio and mbiomics. Among them, Biotia secured the most recent funding round in October, 2026.

Biotia - 2026 Company Profile, Team, Funding & Competitors

Biotia is a series B company based in Brooklyn (United States), founded in 2016 by Niamh O'Hara. It operates as a Provider of sequencing-based solutions for hospitals. Biotia has raised $19.4M in funding from investors like OCA Ventures, Hyperplane and SpringTide. The company has 40 active competitors, including 19 funded and 3 that have exited. Its top competitors include companies like Kallyope, Manus Bio and mbiomics.

Company Details

Provider of sequencing-based solutions for hospitals. The company uses its proprietary bioinformatics technology to fight nosocomial infections and other diseases. The company offers active surveillance of the highest risk units, and incoming patients, and facilitates intervention before patients get sick.

Website: www.biotia.io/
Social
Email ID: *****@biotia.io
Registered Address: 1867 STOCKHOLM ST.,APT. 1,RIDGEWOOD,NY,11385

Key Metrics

Founded Year

2016

Location

Brooklyn, United States

Stage

Series B

Total Funding

$19.4M in 3 rounds

Latest Funding Round

Series B, Oct 01, 2026, $*****

Investors

OCA Ventures & 17 more

Ranked

6^th among 40 active competitors

Employee Count

27 as on Sep 30, 2026

Similar Companies

Kallyope & 51 more

View Biotia's full profile

Biotia is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOTIA, INC. CIN: 5347761 , United States, Active	May 24, 2018	-	-	-

Biotia has raised a total funding of $19.4M over 3 rounds. Its first funding round was on Dec 10, 2019. Its latest funding round was a Series B round on Oct 01, 2026 for $*****. 9 investors participated in its latest round. Biotia has 18 institutional investors.

Here is the list of recent funding rounds of Biotia:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 01, 2026	3729375	Series B	2616166	8030552	5705874	8715174
Aug 23, 2022	5000729	Series A	4189572	9069129	9804259	Continuum Health Ventures & 4 more
Dec 10, 2019	3197689	Seed	2980504	2258913	Hyperplane & 3 more	1832407

Access funding benchmarks and valuations. Sign up today!

View details of Biotia's funding rounds and investors

The founders of Biotia is Niamh O'Hara. Niamh O'Hara is the CEO of Biotia.

Here are the details of Biotia's key team members:

Niamh O'Hara: Co-Founder & CEO of Biotia.
Contact Info: 1 email address

View details of Biotia's Founder profiles and Board Members

Biotia's employee count trend

Biotia has 27 employees as of Sep 26. Here is Biotia's employee count trend over the years:

Uncover Biotia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biotia include Kallyope, Manus Bio and mbiomics. Here is the list of Top 10 competitors of Biotia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Kallyope 2014, New York City (United States), Series D	Discovering novel therapeutics for neurological and metabolic diseases	$479M	The Column Group, Illumina Ventures & 21 others	59/100
2nd	Manus Bio 2011, Cambridge (United States), Series B	Developer of phytochemicals using microbial fermentation	$125M	Nelstone Ventures, BBGI & 17 others	57/100
3rd	mbiomics 2020, Munich (Germany), Series A	Provider of a genomic-based platform for microbiome-based therapeutics development	$35.2M	MIG Fonds, Bayern Kapital & 1 others	55/100
4th	BioCorteX 2021, London (United Kingdom), Seed	Developer of human-microbiome platform for drug development	$5M	Sofinnova Partners, Hoxton Ventures & 1 others	54/100
5th	MicroByre 2017, San Francisco (United States), Seed	Developer of genetically engineered strains of microorganisms	$7.67M	Climate Capital, Planetary Technologies & 6 others	44/100
6th	Biotia 2016, Brooklyn (United States), Series B	Provider of sequencing-based solutions for hospitals	$19.4M	OCA Ventures, Leawood Venture Capital & 16 others	59/100
7th	Photanol 2008, Amsterdam (Netherlands), Series A	Provider of technology for light-powered bio-production of chemicals	$9.3M	EIC Fund, UvA Ventures Holding & 3 others	40/100
8th	Triton 2013, San Diego (United States), Series A	Producer of plant-based protein from red and green algae	$5M	Lanx Capital, HHS & 1 others	40/100
9th	Murren Biotechnology 2015, Beijing (China), Series C	Developer of microbial separation and cultivation technologies	$50.6M	Guangzhou Yuexiu Industrial Investment Fund Management, SDIC ... & 2 others	40/100
10th	Kaleido Biosciences 2015, Cambridge (United States), Deadpooled	Developer of microbiome metabolic therapies for inflammatory conditions	$165M	Fidelity Investments, Rock Springs Capital ... & 7 others	39/100